This is the case for PRRX1 whose expression in breast carcinoma cells inhibits stemness, while its silencing, leading to MET, is required for metastasis outgrowth associated with stem‐like properties (Ocaña et al., 2012). The gene discussed is PRRX1; the disease is breast carcinoma.